Skip to main content

Peer Review reports

From: Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial

Original Submission
26 Feb 2020 Submitted Original manuscript
7 Apr 2020 Author responded Author comments - Charlien Berghen
Resubmission - Version 2
7 Apr 2020 Submitted Manuscript version 2
Publishing
12 Apr 2020 Editorially accepted
24 May 2020 Article published 10.1186/s12885-020-06853-x

You can find further information about peer review here.

Back to article page